NMI Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NMI Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $706.44M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $650.97M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $579.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $523.35M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $485.07M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $433.28M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $378.77M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $275.03M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $182.74M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $123.82M | Feb 14, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $388.93M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $360.11M | Feb 12, 2026 |
| FY2023 | Dec 31, 2023 | $83.41M | Feb 15, 2024 |
| FY2023 | Sep 30, 2023 | $83.96M | Feb 15, 2024 |
| FY2023 | Jun 30, 2023 | $80.28M | Feb 15, 2024 |
| FY2023 | Mar 31, 2023 | $74.46M | Feb 15, 2024 |
| FY2023 | Dec 31, 2022 | $72.94M | Feb 15, 2024 |
| FY2023 | Sep 30, 2022 | $76.84M | Feb 15, 2024 |
| FY2023 | Jun 30, 2022 | $75.44M | Feb 15, 2024 |
| FY2023 | Mar 31, 2022 | $67.68M | Feb 15, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $419.30M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $393.60M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $342.68M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $313.39M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $325.72M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $252.60M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $208.15M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $145.86M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $67.76M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $71.94M | Feb 14, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.78M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $6.91M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $9.37M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $10.57M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $12.24M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $12.16M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $9.96M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $8.06M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $8.51M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $11.47M | Feb 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.84B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $3.35B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.94B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $2.52B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.45B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $2.17B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $1.36B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $1.09B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $894.85M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $839.90M | Feb 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.13B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.01B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $902.30M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $884.80M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $797.08M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $434.40M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $390.54M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $385.77M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $364.39M | Feb 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.59B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.22B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.93B | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $1.61B | Feb 12, 2026 |
| FY2024 | Dec 31, 2021 | $1.57B | Feb 14, 2025 |
| FY2023 | Dec 31, 2020 | $1.37B | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | $930.42M | Feb 15, 2023 |
| FY2021 | Dec 31, 2018 | $701.50M | Feb 16, 2022 |
| FY2020 | Dec 31, 2017 | $509.08M | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | $475.51M | Feb 14, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.24M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $3.24M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $3.24M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $3.24M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $3.24M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $3.24M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $3.24M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $3.24M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $3.24M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $3.24M | Feb 16, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.97B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.58B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.22B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $901.04M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $608.14M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $377.01M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $205.45M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $33.49M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | ($74.16M) | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | ($96.72M) | Feb 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $19.20M | Feb 16, 2018 |
| FY2017 | Dec 31, 2016 | $47.75M | Feb 16, 2018 |
| FY2017 | Dec 31, 2015 | $57.32M | Feb 16, 2018 |
| FY2017 | Dec 31, 2014 | $103.02M | Feb 16, 2018 |
| FY2016 | Dec 31, 2013 | $55.93M | Feb 17, 2017 |
| FY2015 | Dec 31, 2012 | $485.86M | Feb 19, 2016 |
| FY2014 | Dec 31, 2011 | $0 | Feb 20, 2015 |
| FY2013 | May 18, 2011 | $0 | Mar 12, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $396.05M | Feb 15, 2023 |
| FY2022 | Dec 31, 2021 | $394.62M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $393.30M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $145.76M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $146.76M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $143.88M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $144.35M | Feb 16, 2018 |
| FY2016 | Dec 31, 2015 | $143.94M | Feb 17, 2017 |
| FY2015 | Dec 31, 2014 | $0 | Feb 19, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 12, 2026 |
| FY2023 | Dec 31, 2023 | 1 | Feb 15, 2024 |
| FY2023 | Sep 30, 2023 | 1 | Feb 15, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Feb 15, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Feb 15, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 15, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 15, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Feb 15, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Feb 15, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 12, 2026 |
| FY2023 | Dec 31, 2023 | 1 | Feb 15, 2024 |
| FY2023 | Sep 30, 2023 | 1 | Feb 15, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Feb 15, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Feb 15, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 15, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 15, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Feb 15, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Feb 15, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 76.29M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 78.60M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 80.88M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | 83.55M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | 85.79M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | 85.16M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | 68.36M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 66.32M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | 60.52M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | 59.15M | Feb 16, 2018 |